| impact of prophylaxis with cytogam alone on the incidence of cmv viremia in cmv-seropositive lung transplant recipients. | cytomegalovirus (cmv) infection remains a serious problem after lung transplantation. the purpose of this study was to evaluate the efficacy of cytogam, a cmv hyperimmune globulin (cmv-igiv), as cmv prophylaxis after lung transplantation. | 2003 | 12873543 |
| respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. | bronchiolitis obliterans syndrome (bos) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. to identify unique risk factors for bos and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. the demographic and clinical characteristics of this population were analyzed for an association between bos or death and potential ... | 2004 | 15130908 |
| a phase 1 study of 4 live, recombinant human cytomegalovirus towne/toledo chimeric vaccines. | human cytomegalovirus (hcmv) infection acquired in utero often results in severe consequences, including mental retardation and deafness. although not evaluated for this indication, live attenuated hcmv vaccines based on the towne strain are well-tolerated and have demonstrated moderate efficacy in other clinical settings. | 2006 | 16619181 |
| uveitis referral pattern in a midwest university eye center. | we determined the referral pattern and visual prognosis for patients with uveitis at a tertiary university eye center in the midwestern u.s. over a five-year period. a retrospective chart review was conducted on 853 patients seen in the department of ophthalmology and visual sciences (dovs) at washington university and the barnes retina institute (bri) from 1990 to 1995. recorded data on each patient included demographic information, anatomic diagnosis, etiologic diagnosis, pattern of uveitis, a ... | 2003 | 14704900 |